Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling

International Journal of Cancer

Volumn 134, Issue 8, 2014, Pages 1785-1795

  Hasegawa, Tsuyoshi ^a   Yashiro, Masakazu ^a   Nishii, Takafumi ^a   Matsuoka, Junko ^a   Fuyuhiro, Yuhiko ^a   Morisaki, Tamami ^a   Fukuoka, Tatsunari ^a   Shimizu, Kiyoshi ^b   Shimizu, Toshiyuki ^b   Miwa, Atsushi ^b   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

cancer stem cell; cancer associated fibroblast; microenvironment; scirrhous gastric cancer; TGF

Indexed keywords

CANCER STEM CELL; CANCER-ASSOCIATED FIBROBLAST; MICROENVIRONMENT; SCIRRHOUS GASTRIC CANCER; TGFΒ;

ACTINS; ADENOCARCINOMA, SCIRRHOUS; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FIBROBLASTS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASTIC STEM CELLS; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SPHEROIDS, CELLULAR; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA; TUMOR MICROENVIRONMENT;

EID: 84893760814     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28520     Document Type: Article

References (27)

1. Iwasaki H, Suda T,. Cancer stem cells and their niche. Cancer Sci 2009; 100: 1166-72.
2. Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006; 66: 9339-44. (Pubitemid 44623625)
3. Nishii T, Yashiro M, Shinto O, et al. Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma. Cancer Sci 2009; 100: 1397-402.
4. Glinsky GV, Berezovska O, Glinskii AB,. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 2005; 115: 1503-21. (Pubitemid 40814659)
5. Goodell MA, Rosenzweig M, Kim H, et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 1997; 3: 1337-45. (Pubitemid 28011033)
6. Fukuda K, Saikawa Y, Ohashi M, et al. Tumor initiating potential of side population cells in human gastric cancer. Int J Oncol 2009; 34: 1201-7.
7. Japanese Gastric Cancer A. Japanese Classification of Gastric Carcinoma, 2nd English edn. Gastric Cancer 1998; 1: 10-24.
8. Hippo Y, Yashiro M, Ishii M, et al. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 2001; 61: 889-95. (Pubitemid 32174397)
9. Jass JR, Sobin LH, Watanabe H,. The World Health Organization's histologic classification of gastrointestinal tumors. A commentary on the second edition. Cancer 1990; 66: 2162-7.
10. Nakazawa K, Yashiro M, Hirakawa K,. Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma. Cancer Res 2003; 63: 8848-52. (Pubitemid 38064064)
11. Yashiro M, Chung YS, Sowa M,. Role of orthotopic fibroblasts in the development of scirrhous gastric carcinoma. Jpn J Cancer Res 1994; 85: 883-6. (Pubitemid 24294744)
12. Yashiro M, Hirakawa K,. Cancer-stromal interactions in scirrhous gastric carcinoma. Cancer Microenviron 2010; 3: 127-35.
13. Fuyuhiro Y, Yashiro M, Noda S, et al. Upregulation of cancer-associated myofibroblasts by TGF-beta from scirrhous gastric carcinoma cells. Br J Cancer 2011; 105: 996-1001.
14. Kato Y, Yashiro M, Noda S, et al. Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma. Br J Cancer 2010; 102: 898-907.
15. Yashiro M, Chung YS, Nishimura S, et al. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. Clin Exp Metastasis 1996; 14: 43-54. (Pubitemid 26008959)
16. Motoyama T, Hojo H, Watanabe H,. Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 1986; 36: 65-83. (Pubitemid 16187837)
17. Ehata S, Hanyu A, Fujime M, et al. Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line. Cancer Sci 2007; 98: 127-33. (Pubitemid 44803931)
18. Schmuck R, Warneke V, Behrens HM, et al. Genotypic and phenotypic characterization of side population of gastric cancer cell lines. Am J Pathol 2011; 178: 1792-804.
19. Pfaffl MW,. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
20. Fuyuhiro Y, Yashiro M, Noda S, et al. Cancer-associated orthotopic myofibroblasts stimulates the motility of gastric carcinoma cells. Cancer Sci 2012; 103: 797-805.
21. Ikushima H, Todo T, Ino Y, et al. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 2009; 5: 504-14.
22. Penuelas S, Anido J, Prieto-Sanchez RM, et al. TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 2009; 15: 315-27.
23. Naka K, Hoshii T, Muraguchi T, et al. TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 2010; 463: 676-80.
24. Ehata S, Johansson E, Katayama R, et al. Transforming growth factor-beta decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells. Oncogene 2011; 30: 1693-705.
25. Miyazono K, Suzuki H, Imamura T,. Regulation of TGF-beta signaling and its roles in progression of tumors. Cancer Sci 2003; 94: 230-4. (Pubitemid 36575887)
26. Massague J, Seoane J, Wotton D,. Smad transcription factors. Genes Dev 2005; 19: 2783-810. (Pubitemid 41739965)
27. Webber J, Steadman R, Mason MD, et al. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res 2010; 70: 9621-30.